Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease
Peleg, L.; Gazit, E.; Goldman, B.; Akstein, E.
Harefuah 129(11): 475-480
1995
ISSN/ISBN: 0017-7768 PMID: 8846957 Document Number: 449594
Document emailed within 1 workday
Related Documents
Kaback, M.M. 1982: Screening for reproductive counseling: social, ethical, and medicolegal issues in the Tay-Sachs disease experience Progress in Clinical and Biological Research 103 Pt B: 447-459Fontaine, G.; Maillard, E.; Farriaux, J.P.; Strecker, G.; Montreuil, J.; Resibois, A.; Tondeur, M.; Jonniaux, G.; Loeb, H. 1970: Clinical, biochemical and ultrastructural study of a case of Tay-Sachs disease with hexosaminidase deficiency Archives Francaises de Pediatrie 27(4): 447-448
Rivin, B.E.; Slome, C. 1977: Screening programs for Tay-Sachs disease in North Carolina North Carolina Medical Journal 38(11): 649-651
Tsukahara, T.; Kadota, R.L. 1977: Economic considerations in genetic screening programs for Tay-Sachs disease Progress in Clinical and Biological Research 18: 319-327
Padeh, B.; Shahar, S.; Navon, R.; Modan, M.; Goldman, B. 1977: Voluntary mass screening program for Tay-Sachs disease in Israel Harefuah 92(11): 481-485
Katayama, M.; Kobayashi, T.; Ohnishi, A.; Goto, I.; Kuroiwa, Y. 1984: Biochemical and pathological studies on a carrier of Fabry's disease manifesting bouts of pain in the extremities Rinsho Shinkeigaku 24(6): 575-580
Furukawa, Y.; Shimadzu, M.; Hornykiewicz, O.; Kish, S.J. 1998: Molecular and biochemical aspects of hereditary progressive and dopa-responsive dystonia Advances in Neurology 78: 267-282
Evans, P.R. 1977: Tay-Sachs screening in Britain Progress in Clinical and Biological Research 18: 55-59
Garber, A.P.; Platt, L.D.; Wang, S.J.; Jam, K.; Carlson, D.E.; Rotter, J.I. 1993: Determinants of utilization of Tay-Sachs screening Obstetrics and Gynecology 82(3): 460-463
Kushnick, T.; Diamond, N. 1976: Mass screening in new Jersey for Tay-Sachs gene Journal of the Medical Society of New Jersey 73(4): 303-307
Lowden, J.A.; Davidson, J. 1977: Tay-Sachs screening and prevention: the Canadian experience Progress in Clinical and Biological Research 18: 37-46
Zinterhofer, L.; Schuttringer, G. 1976: Kinetic determination of hexosaminidases for Tay-Sachs heterozygote screening Clinical Chemistry 22(10): 1631-1634
Torre, R.; Savino, A.; Venturi, P.; Taverna, R.; Triacca, R.; Coli, A.; Bernasconi, D.; Del Monte, P.; Marugo, M. 2001: Genotypic sex and phenotypic sex: clinical, biochemical and molecular aspects in a patient with male hypogonadism and 46XX-45XO karyotype Recenti Progressi in Medicina 92(12): 747-750
Vuthiwong, C.; Panichkul, P.; Punpuckdeekoon, P. 2012: Causes and attitude of husbands toward thalassemic carrier screening test when their partners have abnormal screening tests Journal of the Medical Association of Thailand 95(Suppl 5): S162-S167
Dandana, A.; Ferchichi, S.; Khedhiri, S.; Chkioua, L.; Jaidane, Z.; Monastiri, K.; Ben Khelifa, S.; Ben Mansour, R.; Maire, I.; Froissart, R.; Bonnet, V.; Laradi, S.; Miled, A. 2007: Biochemical and molecular diagnosis of Gaucher disease in Tunisia Annales de Biologie Clinique 65(6): 647-652
Goberna Tricas, J.; Martín-Arribas, M.C.ón. 2007: Neonatal screening for congenital metabolic pathologies. Ethical and social aspects. Implications for nurses and midwives Revista de Enfermeria 30(2): 20-26
Korf, J.; van Praagen, H.M.; Lakke, J.P. 1975: Parkinson's disease: neuro-anatomical, biochemical and pharmicotherapeutic aspects Nederlands Tijdschrift Voor Geneeskunde 119(36): 1373-1378
García de Yébenes, J.; Bazán, E.; Mena, M.A.; Muradas, V.; Reiriz, J.; Romero, J.; González-Elipe, J. 1986: Clinical and biochemical aspects of early-onset Parkinson's disease Revista Clinica Espanola 178(7): 343-346
Gelbart, M. 1998: Tay-Sachs disease Nursing Times 94(11): 39
Novoa, F.; Colombo, M.; Clericus, J. 1974: Tay-Sachs disease Revista Chilena de Pediatria 45(6): 495-499